Chunsheng He

1.9k total citations
40 papers, 1.5k citations indexed

About

Chunsheng He is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Chunsheng He has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biomedical Engineering, 11 papers in Molecular Biology and 11 papers in Biomaterials. Recurrent topics in Chunsheng He's work include Nanoparticle-Based Drug Delivery (10 papers), Nanoplatforms for cancer theranostics (10 papers) and Molecular Sensors and Ion Detection (6 papers). Chunsheng He is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Nanoplatforms for cancer theranostics (10 papers) and Molecular Sensors and Ion Detection (6 papers). Chunsheng He collaborates with scholars based in Canada, China and United States. Chunsheng He's co-authors include Xiao Yu Wu, Andrew M. Rauth, Yufang Xu, Weiping Zhu, Xuhong Qian, Jeffrey T. Henderson, Ping Cai, Chusen Huang, Tian Zhang and Warren D. Foltz and has published in prestigious journals such as ACS Nano, Biomaterials and Advanced Functional Materials.

In The Last Decade

Chunsheng He

38 papers receiving 1.4k citations

Peers

Chunsheng He
Jelena M. Janjic United States
Hyejin Park South Korea
Diana Velluto Switzerland
Yuh Baba Japan
Emilia Peuhu Finland
Yeong Mi Lee South Korea
Jelena M. Janjic United States
Chunsheng He
Citations per year, relative to Chunsheng He Chunsheng He (= 1×) peers Jelena M. Janjic

Countries citing papers authored by Chunsheng He

Since Specialization
Citations

This map shows the geographic impact of Chunsheng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunsheng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunsheng He more than expected).

Fields of papers citing papers by Chunsheng He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunsheng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunsheng He. The network helps show where Chunsheng He may publish in the future.

Co-authorship network of co-authors of Chunsheng He

This figure shows the co-authorship network connecting the top 25 collaborators of Chunsheng He. A scholar is included among the top collaborators of Chunsheng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunsheng He. Chunsheng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Chunsheng, Azhar Z. Abbasi, Meng Tian, et al.. (2025). Brain microenvironment-remodeling nanomedicine improves cerebral glucose metabolism, mitochondrial activity and synaptic function in a mouse model of Alzheimer's disease. Biomaterials. 318. 123142–123142. 6 indexed citations
2.
He, Chunsheng, et al.. (2025). Assessing Correlation between Surrogate Endpoints and Overall Survival for Oncology Clinical Trials. Clinical Pharmacology & Therapeutics. 117(6). 1706–1717.
3.
Abbasi, Azhar Z., Chunsheng He, HoYin Lip, et al.. (2024). Targeting DNA damage repair mechanism by using RAD50-silencing siRNA nanoparticles to enhance radiotherapy in triple negative breast cancer. Materials Today Bio. 28. 101206–101206. 4 indexed citations
4.
Alradwan, Ibrahim, Tian Zhang, HoYin Lip, et al.. (2024). Nanoparticulate drug combination inhibits DNA damage repair and PD-L1 expression in BRCA-mutant and wild type triple-negative breast cancer. Journal of Controlled Release. 377. 661–674. 5 indexed citations
5.
He, Chunsheng, Xin Jin, Lihong Weng, et al.. (2024). Electrochemical immunoassay for gastric cancer biomarker pepsinogen I detection based on PdAgPt/MoS2. Biomedical Materials. 20(2). 25001–25001. 1 indexed citations
6.
He, Chunsheng, Azhar Z. Abbasi, Taksim Ahmed, et al.. (2023). Brain‐Penetrating and Disease Site‐Targeting Manganese Dioxide‐Polymer‐Lipid Hybrid Nanoparticles Remodel Microenvironment of Alzheimer's Disease by Regulating Multiple Pathological Pathways. Advanced Science. 10(12). e2207238–e2207238. 28 indexed citations
7.
Rottey, Sylvie, Jeffrey Clarke, Kyaw Aung, et al.. (2022). Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors. EUR Research Repository (Erasmus University Rotterdam). 40 indexed citations
8.
Jin, Feng, et al.. (2022). Antibiotics use and risk of colorectal neoplasia: An updated meta-analysis. International Journal of Colorectal Disease. 37(11). 2291–2301. 6 indexed citations
9.
Zhang, Ruixue, Jason Li, Tian Zhang, et al.. (2018). Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy – an illustration with firsthand examples. Acta Pharmacologica Sinica. 39(5). 825–844. 80 indexed citations
10.
Zhang, Tian, Preethy Prasad, Ping Cai, et al.. (2017). Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice. Acta Pharmacologica Sinica. 38(6). 835–847. 54 indexed citations
11.
He, Chunsheng, Ping Cai, Jason Li, et al.. (2016). Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer. Journal of Controlled Release. 246. 98–109. 81 indexed citations
12.
He, Chunsheng, et al.. (2016). A New Method for Evaluating Actual Drug Release Kinetics of Nanoparticles inside Dialysis Devices via Numerical Deconvolution. Journal of Controlled Release. 243. 11–20. 39 indexed citations
13.
Abbasi, Azhar Z., Preethy Prasad, Ping Cai, et al.. (2015). Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer. Journal of Controlled Release. 209. 186–196. 62 indexed citations
14.
He, Chunsheng, Long Ren, Weiping Zhu, Yufang Xu, & Xuhong Qian. (2015). Removal of mercury from aqueous solution using mesoporous silica nanoparticles modified with polyamide receptor. Journal of Colloid and Interface Science. 458. 229–234. 33 indexed citations
15.
Huang, Chusen, et al.. (2012). A glucose-responsive controlled release system using glucose oxidase-gated mesoporous silica nanocontainers. Chemical Communications. 48(76). 9522–9522. 77 indexed citations
16.
He, Chunsheng, Daniel E. Weeks, Steven Buyske, et al.. (2011). Enhanced genetic maps from family-based disease studies: population-specific comparisons. BMC Medical Genetics. 12(1). 15–15. 5 indexed citations
17.
Li, Wentian, Chunsheng He, & Jan Freudenberg. (2010). A mathematical framework for examining whether a minimum number of chiasmata is required per metacentric chromosome or chromosome arm in human. Genomics. 97(3). 186–192. 3 indexed citations
18.
Nielsen, David A., Fei Ji, Vadim Yuferov, et al.. (2010). Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction. Psychiatric Genetics. 20(5). 207–214. 48 indexed citations
19.
Matthews, Abigail G., Jia Li, Chunsheng He, Jürg Ott, & Mariza de Andrade. (2009). Adjusting for HLA-DRβ1 in a genome-wide association analysis of rheumatoid arthritis and related biomarkers. BMC Proceedings. 3(S7). S12–S12. 2 indexed citations
20.
He, Chunsheng, Weiping Zhu, Yufang Xu, Tao Chen, & Xuhong Qian. (2009). Trace mercury (II) detection and separation in serum and water samples using a reusable bifunctional fluorescent sensor. Analytica Chimica Acta. 651(2). 227–233. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026